BIOPLUS ACQUISITION Stock Price, News & Analysis

BIOS NASDAQ

Company Description

BIOPLUS ACQUISITION (NASDAQ: BIOS) is a publicly traded company.

BIOS stock has declined 100.0% over the past year.

This page provides a comprehensive overview of BIOS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-100%

Performance 1 year

$0.0

Market Cap

19.4M

Shares outstanding

BIOPLUS ACQUISITION (BIOS) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All

October 4, 2023

-0.28%

BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate

acquisition

December 7, 2021

+134.45%

Riverbed|Aternity Announces Appointment of New Board of Directors

management

December 6, 2021

+134.45%

BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering

IPO offering acquisition

December 3, 2021

+134.45%

BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering

IPO offering acquisition

BIOPLUS ACQUISITION has 4 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition, management, IPO, offering. View all BIOS news →

SEC Filings

View All

No SEC filings available for BIOS.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months